Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02268071Completed
Open-label, single-arm trial, sponsored by CHRU de Nancy - Hôpital Central. Primary endpoint: Rate of normotensive patients at 1 year. Started Mar 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02268071.